Advertisement
Singapore markets close in 3 hours 40 minutes
  • Straits Times Index

    3,279.99
    -13.14 (-0.40%)
     
  • Nikkei

    37,691.41
    -768.67 (-2.00%)
     
  • Hang Seng

    17,259.85
    +58.58 (+0.34%)
     
  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     
  • Bitcoin USD

    64,159.98
    -2,726.85 (-4.08%)
     
  • CMC Crypto 200

    1,389.61
    -34.49 (-2.42%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Gold

    2,328.70
    -9.70 (-0.41%)
     
  • Crude Oil

    82.94
    +0.13 (+0.16%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     
  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     
  • PSE Index

    6,580.59
    +7.84 (+0.12%)
     

Is This The Turning Point for Inovio?

Is This The Turning Point for Inovio?

It seems such a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered one of the leaders in the hunt for a COVID-19 vaccine -- but the biotech was left in the dust by peers and many investors have given up on the stock. In the past 12 months, shares of Inovio are down 45% even as the broader market took off. Let's see whether the company is finally ready to turn things around.